Luisa records from the road this week as she visits AstraZeneca and Sanofi “up north”. Kerry highlights key takes from her meetings with GSK at the recent Berenberg UK conference. The duo also discuss the longevity of Sanofi’s Dupixent, expectations ahead of Lilly’s orforglipron launch and the Medicare obesity BALANCE pilot programme.